Therapeutic targets in malignant glioblastoma microenvironment
about
Inherited variation in immune genes and pathways and glioblastoma riskCase-specific potentiation of glioblastoma drugs by pterostilbeneSTAT6 expression in glioblastoma promotes invasive growthMolecularly targeted therapies for malignant glioma: rationale for combinatorial strategies.Molecular targeting of glioblastoma: Drug discovery and therapiesTemozolomide modifies caveolin-1 expression in experimental malignant gliomas in vitro and in vivo.Choindroitinase ABC I-mediated enhancement of oncolytic virus spread and anti tumor efficacy: a mathematical model.A functional screen identifies miRs that induce radioresistance in glioblastomas.Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in MelanomaA functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma.CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages.Mechanisms of glioma-associated neovascularization.CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.Invariant delineation of nuclear architecture in glioblastoma multiforme for clinical and molecular associationRole of WW domain proteins WWOX in development, prognosis, and treatment response of glioma.Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells.In vivo radiation response of proneural glioma characterized by protective p53 transcriptional program and proneural-mesenchymal shift.Towards tailored therapy of glioblastoma multiforme.Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment.Interleukins in glioblastoma pathophysiology: implications for therapy.Notch3 signaling-mediated melanoma-endothelial crosstalk regulates melanoma stem-like cell homeostasis and niche morphogenesis.STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human Glioblastoma.Paxillin functions as an oncogene in human gliomas by promoting cell migration and invasion.RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration.Hypoxia regulates Toll-like receptor-9 expression and invasive function in human brain cancer cells in vitro.Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells.Anti-inflammatory Effects of Atorvastatin by Suppressing TRAF3IP2 and IL-17RA in Human Glioblastoma Spheroids Cultured in a Three-dimensional Model: Possible Relevance to Glioblastoma Treatment.Cullin1 regulates proliferation, migration and invasion of glioma cells.Metastasis tumor-associated protein-2 knockdown suppresses the proliferation and invasion of human glioma cells in vitro and in vivo.Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.Heterogeneous phenotype of human glioblastoma: in vitro study.
P2860
Q28383820-CECB25BD-0B08-4F60-8CB5-1E7A7A29C2F0Q29048651-B5976768-8CDB-43AB-8A49-A64B15021908Q30431789-A5363A25-3814-412A-8764-5239022DB3D8Q33644407-E7F6B5DE-91A2-4461-AC36-CFC053117B9BQ33911283-77F27DB9-A629-4CC6-850A-1A3453CECC38Q34754083-96DCDA1D-67A2-403D-888E-C2F62710069FQ35210355-B186E6B7-12EB-4C7F-8168-04F778681950Q35285532-5512D8DF-0D0B-4AA8-B80F-1A126F3B5593Q35463820-64D7D1EB-B1F7-4F30-9CE7-A1243ABC8A17Q35552628-8593A094-6A4C-40D8-AE3D-C94E0A02CD73Q36127405-33B90C36-78F7-4864-820F-9CE63A18BEFBQ36295477-92550C24-5185-4D85-9896-2A3F0DF5FE5CQ36295548-FAF454BF-8338-42C8-B7ED-8B1A617E94D5Q36511945-65C24612-EA71-4A1B-991D-E760ED646E68Q37057349-E8A84A37-379A-4F0E-9F8D-43F5C6DCB9F1Q37071045-DFF9984B-2E21-4A94-B363-1D2F1B7B05ECQ37641240-D865E1B6-5014-4C7B-A9BF-C2D2C52BB32CQ37702083-351900DC-B8F2-4B39-A967-363E1A2AF6F5Q37908815-AB5B38CE-ED15-4DE5-994F-4A17FC72BD89Q37970682-1510CCE7-436D-4CFA-85D6-A82237829A7DQ38051761-D0B712DF-1304-4EB2-9922-E3C1CCEB9D08Q38717772-57AB66F4-DCC3-425B-83AA-35BF3BC99AAEQ38903930-AC7B6845-C256-459D-9268-BCD814075F1AQ39147223-ACD6431A-B4E6-4C4F-A7ED-F848FBBE3A10Q39472960-91F159A5-FFFD-4AC8-B1BE-2E71CF87B04CQ40893702-705ADE0A-8BB0-41F0-A5A6-0D18095F6075Q42371488-BDB8B81A-B324-4E84-B907-F1D3CE5BC7CEQ48268624-7CE13EC6-D103-4402-A27A-4FA5C97D1246Q48556580-04199258-A7BD-4941-97E0-D16776C46147Q48645806-55749E8E-EB0B-469E-8BB8-7AC62BF5334FQ48753389-AC6A7CC3-754C-45EF-A988-9942ED55E488Q50798445-1ED311F8-685A-45C8-9F6E-8850F04560BC
P2860
Therapeutic targets in malignant glioblastoma microenvironment
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic targets in malignant glioblastoma microenvironment
@en
Therapeutic targets in malignant glioblastoma microenvironment.
@nl
type
label
Therapeutic targets in malignant glioblastoma microenvironment
@en
Therapeutic targets in malignant glioblastoma microenvironment.
@nl
prefLabel
Therapeutic targets in malignant glioblastoma microenvironment
@en
Therapeutic targets in malignant glioblastoma microenvironment.
@nl
P2093
P2860
P1476
Therapeutic targets in malignant glioblastoma microenvironment
@en
P2093
Ashwatha Narayana
David Zagzag
Elizabeth W Newcomb
Mary Helen Barcellos-Hoff
P2860
P304
P356
10.1016/J.SEMRADONC.2009.02.004
P577
2009-07-01T00:00:00Z